Cargando…
Challenges of targeting BRAF V600E mutations in adult primary brain tumor patients: a report of two cases
AIM: Therapeutic targeting of BRAF alterations in primary brain tumor patients has demonstrated clinical activity in case reports and early trials; however, there is limited high-level evidence of the efficacy. PATIENTS & RESULTS: Targeting BRAF V600E mutations with concurrent dabrafenib and tra...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Future Medicine Ltd
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912849/ https://www.ncbi.nlm.nih.gov/pubmed/31818130 http://dx.doi.org/10.2217/cns-2019-0018 |